1. An investigation into drug products withdrawn from the EU market between 2002 and 2011 for safety reasons and the evidence used to support the decision-making. Issue 1 (15th January 2014) Authors: McNaughton, Rhian; Huet, Gwenaël; Shakir, Saad Journal: BMJ open Issue: Volume 4:Issue 1(2014) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Pharmacokinetics of doxorubicin following concomitant intravenous administration of olaratumab (IMC‐3G3) to patients with advanced soft tissue sarcoma. (10th December 2019) Authors: Villalobos, Victor M.; Mo, Gary; Agulnik, Mark; Pollack, Seth M.; Rushing, Daniel A.; Singh, Arun; Van Tine, Brian A.; McNaughton, Rhian; Decker, Rodney L.; Zhang, Wei; Shahir, Ashwin; Cronier, Damien M. Journal: Cancer medicine Issue: Volume 9:Number 3(2020) Page Start: 882 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗